Video-based Intervention Study to Prevent HIV/Sexually Transmitted Diseases (STDs) Among STD Clinic Patients
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00137670 |
|
Recruitment Status :
Completed
First Posted : August 30, 2005
Last Update Posted : September 27, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| HIV Infections Sexually Transmitted Diseases | Device: Video-based HIV/STD prevention intervention | Not Applicable |
Approximately 15 million incident cases of sexually transmitted diseases (STDs) occur annually. As a result, primary prevention of HIV/STDs among persons who have chosen to be sexually active remains a high public health priority. A number of effective interventions to prevent HIV/STDs have been developed, however many require considerable time and resource investments from both service providers and participants. These programs are often difficult to implement and sustain over time. As a result, simple practical interventions that can reduce transmission or acquisition of HIV/STDs among STD clinic patients while being both easily implemented and sustainable are urgently needed, and will ultimately enhance the menu of effective programs that are currently available to the STD clinic population.
The intervention trial was designed to develop and evaluate a video-based HIV/STD prevention intervention for STD clinic clients. The primary goals of this study are to assess whether a brief video-based educational waiting room intervention can reduce STD incidence (STD incidence outcome study) and high risk behavior (behavioral outcome study) among male and female patients attending STD clinics, when compared with patients who receive standard clinic services. This study is being conducted as a multi-site trial in 3 urban STD clinics.
The intervention condition consists of a 23-minute educational video focused on preventing STD and HIV infection shown on a large television in the waiting room. Health promotion posters supplement the video. The control condition consists of the current standard waiting room experience in each city's STD clinic.
In the STD incidence outcome study, groups of patients attending the participating STD clinics are randomly assigned to blocks of clinic weeks to either the intervention or control condition. A waiver of informed consent was obtained whereby no subjects are actively enrolled for this phase of the study. Through a retrospective review of existing medical records and STD surveillance registry data, we will determine and compare the incidence of new STDs over a 12-month period (on average) by assigned waiting room conditions.
In the behavioral outcome study, investigators administer computer-based survey instruments to a random sample of ~1600 male and female patients (800 per arm) both at enrollment and at 3 months following their initial clinic visit. The primary objective of the behavioral study is to assess the effectiveness of the video intervention by comparing levels of high-risk behavior between waiting room conditions at 3 months' follow-up.
| Study Type : | Interventional (Clinical Trial) |
| Enrollment : | 45000 participants |
| Allocation: | Non-Randomized |
| Intervention Model: | Single Group Assignment |
| Masking: | Single |
| Primary Purpose: | Prevention |
| Official Title: | Effectiveness of a Video-based Educational Intervention to Prevent Human Immunodeficiency Virus (HIV) and Sexually Transmitted Diseases (STDs) Among Patients Attending STD Clinics |
| Study Start Date : | April 2002 |
| Actual Primary Completion Date : | March 2006 |
| Actual Study Completion Date : | March 2009 |
- STD Incidence Outcome Study: Compare STD incidence in groups by intervention and control conditions at 3, 6, and 12 months follow-up
- Behavioral Outcome Study: Compare the incidence of risk behavior during the 3 month follow-up period among intervention and control conditions
- STD Incidence Outcome Study: Compare incidence of STD syndromes, and first episode of genital herpes or genital warts in intervention/control conditions
- Behavioral Outcome Study: Compare additional measures of risk between intervention and control conditions at three months follow-up including potential mediators of risk and clinic utilization
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
STD Incidence Outcome Study:
- All medical records for STD clinic patients visiting participating STD clinics during the study period.
Behavioral Outcome Study:
STD clinic patients:
- Not returning for a follow-up visit related to a previously diagnosed problem.
- 18 years of age or older.
- Not known to be HIV-infected by self-report.
- Able to understand and speak English fluently.
- Have not been previously seen as a patient in the clinic during an intervention block when the video was being played.
- Have never received a diagnosis of a condition that necessitates frequent return visits (e.g., genital warts) by self-report.
- Have not previously enrolled in the study.
- Reported being in the clinic waiting room at least 20 minutes.
- Do not plan to move outside the clinic's catchment area during the next 6 months.
- Are willing to provide informed consent for review of their medical record and STD surveillance registry information by study staff.
- Are not known to be pregnant according to self-report (women only).
- Are not known by clinicians or counselors to be seriously ill (e.g. new HIV diagnosis or severe pelvic inflammatory disease [PID]).
- Engaged in intercourse in the last three months.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00137670
| United States, California | |
| California State University, Long Beach | |
| Long Beach, California, United States, 90815 | |
| San Francisco Department of Public Health | |
| San Francisco, California, United States, 94103 | |
| United States, Colorado | |
| Denver Public Health | |
| Denver, Colorado, United States, 80204 | |
| United States, Massachusetts | |
| Education Development Center, Inc. | |
| Newton, Massachusetts, United States, 02458 | |
| Principal Investigator: | Jeff D Klausner, MD, MPH | San Francisco Department of Public Health/ STD Prevention and Control Services | |
| Principal Investigator: | Cornelis A Rietmeijer, MD, PhD | Denver Public Health | |
| Principal Investigator: | Kevin Malotte, DrPH | California State University, Long Beach | |
| Principal Investigator: | Lydia N O'Donnell, Ed.D. | Education Development Center, Inc. |
| Responsible Party: | Centers for Disease Control and Prevention |
| ClinicalTrials.gov Identifier: | NCT00137670 |
| Other Study ID Numbers: |
CDC-NCHSTP-3500 R18/CCR921007 R18/CCR121005 R18/CCR821004 |
| First Posted: | August 30, 2005 Key Record Dates |
| Last Update Posted: | September 27, 2012 |
| Last Verified: | September 2012 |
|
Intervention studies HIV |
|
Sexually Transmitted Diseases Virus Diseases Infection |